124 related articles for article (PubMed ID: 23052433)
1. Demographic determinants of survival in osteosarcoma.
Nathan SS; Healey JH
Ann Acad Med Singap; 2012 Sep; 41(9):390-9. PubMed ID: 23052433
[TBL] [Abstract][Full Text] [Related]
2. Making a case for the socioeconomic determinacy of survival in osteosarcoma.
Nathan SS; Healey JH
Clin Orthop Relat Res; 2013 Mar; 471(3):784-91. PubMed ID: 22972655
[TBL] [Abstract][Full Text] [Related]
3. Increased survival of patients aged 0-29 years with osteosarcoma: A period analysis, 1984-2013.
Wu J; Sun H; Li J; Guo Y; Zhang K; Lang C; Zou C; Ma H
Cancer Med; 2018 Aug; 7(8):3652-3661. PubMed ID: 29992762
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors, disparity, and equity variables impacting prognosis in bone sarcomas of the hand: SEER database review.
Jawad MU; Bayne CO; Farhan S; Haffner MR; Carr-Ascher J; Alvarez E; Thorpe SW; Randall RL
J Surg Oncol; 2021 Dec; 124(8):1515-1522. PubMed ID: 34432316
[TBL] [Abstract][Full Text] [Related]
5. Adverse impact of regional lymph node involvement in osteosarcoma.
Thampi S; Matthay KK; Goldsby R; DuBois SG
Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
[TBL] [Abstract][Full Text] [Related]
6. Pediatric head and neck bone sarcomas: An analysis of 204 cases.
Brady JS; Chung SY; Marchiano E; Eloy JA; Baredes S; Park RCW
Int J Pediatr Otorhinolaryngol; 2017 Sep; 100():71-76. PubMed ID: 28802390
[TBL] [Abstract][Full Text] [Related]
7. Pediatric osteosarcoma: a single institution's experience.
Vijayakumar V; Lowery R; Zhang X; Hicks C; Rezeanu L; Barr J; Giles H; Vijayakumar S; Megason G
South Med J; 2014 Nov; 107(11):671-5. PubMed ID: 25365431
[TBL] [Abstract][Full Text] [Related]
8. The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma.
Cao Z; Zhang Y; Xu Q; Yu X; Liu X; Dai M
Technol Cancer Res Treat; 2021; 20():15330338211066195. PubMed ID: 34918558
[No Abstract] [Full Text] [Related]
9. Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.
Song K; Song J; Lin K; Chen F; Ma X; Jiang J; Li F
Int Orthop; 2019 Aug; 43(8):1983-1991. PubMed ID: 31127366
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma: A Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017.
Cole S; Gianferante DM; Zhu B; Mirabello L
Cancer; 2022 Jun; 128(11):2107-2118. PubMed ID: 35226758
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
12. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of osteosarcoma.
Ottaviani G; Jaffe N
Cancer Treat Res; 2009; 152():3-13. PubMed ID: 20213383
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database.
Duchman KR; Gao Y; Miller BJ
Cancer Epidemiol; 2015 Aug; 39(4):593-9. PubMed ID: 26002013
[TBL] [Abstract][Full Text] [Related]
15. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008.
Duong LM; Richardson LC
J Registry Manag; 2013; 40(2):59-64. PubMed ID: 24002129
[TBL] [Abstract][Full Text] [Related]
16. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
17. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
18. Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Díaz R; Salom M; Baixauli F; Gómez J; Llavador M; Castel V
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e272-7. PubMed ID: 25374283
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base.
Miller BJ; Gao Y; Duchman KR
Cancer Epidemiol; 2017 Aug; 49():112-117. PubMed ID: 28601784
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors to survival of patients with chondroblastic osteosarcoma.
Sun HH; Chen XY; Cui JQ; Zhou ZM; Guo KJ
Medicine (Baltimore); 2018 Sep; 97(39):e12636. PubMed ID: 30278586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
